Your browser doesn't support javascript.
loading
Beneficial impact of Ac3IV, an AVP analogue acting specifically at V1a and V1b receptors, on diabetes islet morphology and transdifferentiation of alpha- and beta-cells.
Mohan, Shruti; Lafferty, Ryan; Tanday, Neil; Flatt, Peter R; Moffett, R Charlotte; Irwin, Nigel.
Afiliação
  • Mohan S; SAAD Centre for Pharmacy and Diabetes, Ulster University, Coleraine, Northern Ireland, United Kingdom.
  • Lafferty R; SAAD Centre for Pharmacy and Diabetes, Ulster University, Coleraine, Northern Ireland, United Kingdom.
  • Tanday N; SAAD Centre for Pharmacy and Diabetes, Ulster University, Coleraine, Northern Ireland, United Kingdom.
  • Flatt PR; SAAD Centre for Pharmacy and Diabetes, Ulster University, Coleraine, Northern Ireland, United Kingdom.
  • Moffett RC; SAAD Centre for Pharmacy and Diabetes, Ulster University, Coleraine, Northern Ireland, United Kingdom.
  • Irwin N; SAAD Centre for Pharmacy and Diabetes, Ulster University, Coleraine, Northern Ireland, United Kingdom.
PLoS One ; 16(12): e0261608, 2021.
Article em En | MEDLINE | ID: mdl-34929019
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vasopressinas / Ilhotas Pancreáticas / Células Secretoras de Glucagon / Células Secretoras de Insulina / Transdiferenciação Celular Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vasopressinas / Ilhotas Pancreáticas / Células Secretoras de Glucagon / Células Secretoras de Insulina / Transdiferenciação Celular Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article